SKOLNICK PHIL (Chief Scientific Officer) received a stock award from OPIANT PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2022ACC: 0001385508-22-000013
Officer· Chief Scientific Officer
Since Oct 2018
+12K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
12K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12K
Price / share
—
Trade value
—
% of position
97.2%
1/4/2022
12.35K→24.35K
Total
Net shares
+12K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/4/2022 | A · Award | +12K | — | — | 97.2% | 12.35K | 24.35K |
| Total | +12K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported